dc.contributor.author |
Shukla, Harish |
|
dc.contributor.author |
Kumar, Vikash |
|
dc.contributor.author |
Singh, A K |
|
dc.contributor.author |
Rastogi, Shivangi |
|
dc.contributor.author |
Khan, S R |
|
dc.contributor.author |
Siddiqi, M I |
|
dc.contributor.author |
Krishnan, M Y |
|
dc.contributor.author |
Akhtar, M S |
|
dc.date.accessioned |
2016-03-15T08:51:03Z |
|
dc.date.available |
2016-03-15T08:51:03Z |
|
dc.date.issued |
2015 |
|
dc.identifier.citation |
International Journal of Biological Macromolecules 2015, 78,137–141 |
en |
dc.identifier.uri |
http://hdl.handle.net/123456789/1605 |
|
dc.description.abstract |
Combating tuberculosis requires new therapeutic strategies that not only target the actively dividing bacilli but also the dormant bacilli during persistent infection. Isocitrate lyase (ICL) is a key enzyme of the glyoxylate shunt, crucial for the survival of bacteria in macrophages and mice. MtbICL is considered as one of the potential and attractive drug targets against persistent infection. We report the inhibition of MtbICL by quercetin with IC50 of 3.57 μΜ. In addition, quercetin strongly inhibited the growth of Mtb H37Rv utilizing acetate, rather than glucose as the sole carbon source, suggesting the inhibition of glyoxylate shunt. Quercetin binds at the N-terminus of MtbICL (Kd- 6.68 μM). |
en |
dc.format.extent |
512821 bytes |
|
dc.format.mimetype |
application/pdf |
|
dc.language.iso |
en |
en |
dc.relation.ispartofseries |
CDRI communication number 8956 |
en |
dc.subject |
Isocitrate lyase |
en |
dc.subject |
Quercetin |
en |
dc.subject |
Glyoxylate shunt |
en |
dc.subject |
Mycobacteria |
en |
dc.subject |
Docking |
en |
dc.title |
Isocitrate lyase of Mycobacterium tuberculosis is inhibited by quercetin through binding at N-terminus |
en |
dc.type |
Article |
en |